Kedis ku xidhan hagaha · Dhexdhexaad Heerka
AI ee Badbaadada Dawooyinka iyo Kediska Feejignaanta Dawooyinka
Dib u eegis warbixinaha dhacdooyinka xun, ogaanshaha calaamada iyo koodka habaysan ee ilaalinta badbaadada daroogada ee socodka socodka badeecadaha.
Su'aal 1 ee 8
Waa maxay yoolka koowaad ee ka feejignaanta farmasiga?
Horudhac su'aal kasta8 su'aalo
Jawaabaha iyo sharraxaadaha waxay soo baxayaan markaad qaadanayso kediska.
- Waa maxay yoolka koowaad ee ka feejignaanta farmasiga?
- Ogaanshaha, qiimaynta, iyo ka hortagga waxyeelada daawooyinka ka dib marka la isticmaalo
- Suuqgeynta daawooyinka cusub ee dhakhaatiirta
- Dejinta qiimaha tafaariiqda daawooyinka
- Naqshadeynta baakooyinka kiniinka
- In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
- Only patients’ handwritten signatures
- Medication and adverse-event concepts and their relations
- Only final regulatory decisions
- Only medicine prices
- Waa maxay falanqaynta isku dheelitir la'aanta ayaa lagu ogaadaa xogta dhacdooyinka xun?
- Farqiga qiimaha u dhexeeya summada iyo dawooyinka guud
- Isbitaalkee ayaa soo gudbiyay warbixinadii ugu badnaa
- Lamaanayaasha dhacdada maandooriyaha ah ayaa la soo sheegay in ka badan intii la saadaaliyay fursadaha tirakoobka
- Taariikhaha ay dhacayaan dawooyinka
- What is VigiBase, according to Uppsala Monitoring Centre?
- A database of randomized clinical-trial efficacy results only
- A list of confirmed causal side effects for every medicine
- A commercial catalogue of approved drug prices
- The WHO global database of reported adverse events for medicines and vaccines
- Waa maxay MedDRA loo isticmaalo dhuumaha ilaalinta farmasiga?
- Kalmado caafimaad oo habaysan oo loogu talagalay habaynta falcelinta iyo xaaladaha
- Nooca baakadaha daawada
- App-ka jadwalka dhakhaatiirta
- Nooc ka mid ah iskaanka MRI
- Which sequence does UMC describe in its signal-management process?
- Diagnosis, prescription, dispensing, billing and discharge
- Detection, validation, prioritisation, assessment and communication
- Data collection, automatic causality decision, recall and litigation
- Model training, deployment, billing and marketing
- How should a high disproportionality score in a spontaneous-report database be interpreted?
- As a population incidence rate for all patients
- As a confirmed causal adverse reaction
- As a statistical signal for further assessment, not proof that the drug caused the event
- As proof that no other factor contributed
- Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
- A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
- A product label, a randomized trial, a treatment response, and a safety committee vote
- A hospital admission, a known dose, a genetic profile, and a published case report
- An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter